WAY-620147

CAS No. 515866-67-8

WAY-620147( —— )

Catalog No. M37287 CAS No. 515866-67-8

WAY-620147 is a derivative of N-(2-morpholinoethyl)nicotinamide, which is able to inhibit Monoamine Oxidase.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 29 In Stock
10MG 38 In Stock
25MG 60 In Stock
50MG 86 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    WAY-620147
  • Note
    Research use only, not for human use.
  • Brief Description
    WAY-620147 is a derivative of N-(2-morpholinoethyl)nicotinamide, which is able to inhibit Monoamine Oxidase.
  • Description
    WAY-620147 (compound 6) is an N-(2-morpholinoethyl)nicotinamide derivative that inhibits monoamine oxidase (Monoamine Oxidase). WAY-620147 inhibits MAO-A and MAO-B with IC50s of 26 μM and 55 μM, respectively.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    MAO
  • Recptor
    MAO
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    515866-67-8
  • Formula Weight
    314.18
  • Molecular Formula
    C12H16BrN3O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(NCCN1CCOCC1)C=2C=NC=C(Br)C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Shi L, et al. Design of novel nicotinamides as potent and selective monoamine oxidase a inhibitors. Bioorg Med Chem. 2010 Feb 15;18(4):1659-64.?
molnova catalog
related products
  • Tetrahydroharmine

    Tetrahydroharmine (Leptaflorine) is a natural product found in the stems and large branches of Banisteriopsis caapi cultivar Da Vine. Tetrahydroharmine is a Monoamine oxidase A inhibitor.

  • FCE 28073

    FCE 28073 is a Monoamine oxidase B inibitor with IC50 of 0.45 uM.

  • PF-9601N

    PF-9601N showed high potency and selectivity as a MAO-BI (monoamine oxidase type B inhibitor) and also demonstrated remarkable neuroprotective properties in several in vivo and cellular models of PD.